We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Genentech, Tercica, Insmed Settle Patent Suit

Law360 (March 7, 2007, 12:00 AM EST) -- Biotechnology companies Genentech Inc. and Tercica Inc. settled their lawsuit against rival start-up Insmed Inc. on Wednesday, ending a three-year-long patent scrimmage over Iplex, a drug used to treat hormone deficiencies...
To view the full article, register now.